BridgeMD
Compares treatment options for Physical Health
Official title iMOVE: Virtual Reality PT Versus Traditional PT
ClinicalTrials.gov ID: NCT05876156
What this study is testing
- What it's testing
- This pragmatic, crossover, randomized controlled study evaluates the efficacy of virtual reality assisted physical therapy (VRPT) for improving the physical activity of hospitalized children as compared to traditional physical therapy. This is a pilot study that will be used to identify patient populations that can benefit the most from VRPT and estimate this effect for future studies.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 25
You may be able to join if
- Between age 10-25 years
- Diagnosed with cancer
- Has an active physical therapy consultation
- Anticipated inpatient stay for at least 3-days with the second PT session following between 24-72 hours after the first PT session
- Ability to understand and the willingness to personally sign the written Institutional Review Board (IRB) approved informed consent document by...
You likely can't join if
- Legal guardian does not present to obtain consent.
- Child with a significant neurological condition, or major developmental disability.
- Child with active infection of the face or hand.
- A history of severe motion sickness.
- A history of seizures caused by flashing light.
- Major surgery within the last 48 hours.
See the full eligibility criteria
- Between age 10-25 years
- Diagnosed with cancer
- Has an active physical therapy consultation
- Anticipated inpatient stay for at least 3-days with the second PT session following between 24-72 hours after the first PT session
- Ability to understand and the willingness to personally sign the written Institutional Review Board (IRB) approved informed consent document by Legally Authorized Representative (LAR) if participant \<18 years old or by...
- Ability to understand and the willingness to personally sign the written IRB approved informed assent document for patient \<18 years old.
- Legal guardian does not present to obtain consent.
- Child with a significant neurological condition, or major developmental disability.
- Child with active infection of the face or hand.
- A history of severe motion sickness.
- A history of seizures caused by flashing light.
- Major surgery within the last 48 hours.
- Does not speak English (required for surveys)
- With visual impairments or any degree of developmental delays
- Child on mechanical ventilation or ventilatory support
The study team makes the final eligibility decision.
Where it's taking place
- Palo Alto, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Palo Alto, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.